Archive for July 2025

The Inflation Reduction Act (IRA) in 2025: Impact on Pharma As of July 2025, the Inflation Reduction Act (IRA) remains a transformative force in U.S. healthcare policy, especially for the pharmaceutical industry, even as some of its provisions and funding face adjustments or ongoing debate in Congress. Here’s an up-to-date overview of its current status…